Nova Eye Medical (Nova Eye Medical) ROE % Adjusted to Book Value : -32.48% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Nova Eye Medical ROE % Adjusted to Book Value?

Nova Eye Medical's ROE % for the quarter that ended in Dec. 2023 was -55.86%. Nova Eye Medical's PB Ratio for the quarter that ended in Dec. 2023 was 1.72. Nova Eye Medical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -32.48%.

Nova Eye Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Nova Eye Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Eye Medical ROE % Adjusted to Book Value Chart

Nova Eye Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.58

47.18

-6.46

-435.60

-44.47

Nova Eye Medical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-10.32	-542.80	-40.31	-57.71	-32.48

Competitive Comparison of Nova Eye Medical's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Nova Eye Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Eye Medical's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Nova Eye Medical's ROE % Adjusted to Book Value falls into.

Nova Eye Medical ROE % Adjusted to Book Value Calculation

Nova Eye Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-55.59%	/	1.25
	=	-44.47%

Nova Eye Medical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-55.86%	/	1.72
	=	-32.48%

Nova Eye Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Nova Eye Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Eye Medical (Nova Eye Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nova Eye Medical Ltd (OTCPK:ELXMF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

EYE:Australia

Address

107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067

Website

https://www.nova-eye.com

Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.

Nova Eye Medical (Nova Eye Medical) Headlines

From GuruFocus

ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer

By PRNewswire PRNewswire • 07-30-2018

Nova Eye Medical Announces U.S. Market Clearance of the iTrack� Advance Canaloplasty Device

By Business Wire Business Wire • 04-12-2023